Litcius/Paper detail

Effectiveness of High-Frequency Repetitive Transcranial Magnetic Stimulation in Patients With Spinocerebellar Ataxia Type 3

Menglu Zhou, Mengqiu Qiu, Yi Jin, Dan Li, Chenjuan Tao, Danning Lou, Zhouyao Hu, Yuchen Wang, Zhiyuan You, Yimeng Shao, Yingying Zhu, Mingyue Qu, Xiaodong Lü

2023Journal of Ect14 citationsDOI

Abstract

OBJECTIVE: To investigate the effectiveness of high-frequency repetitive transcranial magnetic stimulation (HF-rTMS) on improvement of clinical symptoms in patients with spinocerebellar ataxia type 3 (SCA3). METHODS: Sixteen SCA3 participants diagnosed by genetic testing were enrolled in this sham-controlled and double-blind trial. They received either a 2-week 10-Hz rTMS intervention or sham stimulation targeting the vermis and cerebellum. The Scale for Assessment and Rating of Ataxia and the International Cooperative Ataxia Rating Scale were completed at baseline and poststimulation. RESULTS: Compared with baseline, the HF-rTMS group demonstrated a significant improvement in the total Scale for Assessment and Rating of Ataxia ( P < 0.0001) and the International Cooperative Ataxia Rating Scale scores ( P = 0.002). After 2-week treatment, the real group exhibited decreasing pattern in 3 subgroups, especially for limb kinetic function ( P < 0.0001). CONCLUSIONS: Short-term HF-rTMS treatment is a potentially promising and feasible tool for rehabilitation in patients with SCA3. Studies with long-term follow-up need to be carried out in the future and further need to assess gait, limb kinetic function, speech and oculomotor disorders.

Topics & Concepts

Transcranial magnetic stimulationSpinocerebellar ataxiaAtaxiaRating scalePhysical therapyPhysical medicine and rehabilitationMedicineGait AtaxiaRandomized controlled trialPsychologyStimulationInternal medicinePsychiatryDevelopmental psychologyTranscranial Magnetic Stimulation StudiesGenetic Neurodegenerative DiseasesVestibular and auditory disorders
Effectiveness of High-Frequency Repetitive Transcranial Magnetic Stimulation in Patients With Spinocerebellar Ataxia Type 3 | Litcius